Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eptacog alfa (activated) 60,000unit inj vials
0211000Z0AAAAAA
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 8mg (400,000unit) inj pfs
0211000Z0AAAKAK
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 8mg (400,000unit) inj vials
0211000Z0AAAGAG
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 1mg (45,000unit) inj vials
0211000Z0AAALAL
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 2mg (90,000unit) inj vials
0211000Z0AAAMAM
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 5mg (225,000unit) inj vials
0211000Z0AAANAN
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptifibatide 20mg/10ml solution for injection vials
0209000X0AAAAAA
|
Eptifibatide | Eptifibatide | Cardiovascular System | No data available |
|
Eptifibatide 75mg/100ml solution for infusion vials
0209000X0AAABAB
|
Eptifibatide | Eptifibatide | Cardiovascular System | No data available |
|
Etamsylate 250mg/2ml solution for injection ampoules
0211000D0AAAAAA
|
Etamsylate | Etamsylate | Cardiovascular System | No data available |
|
Etamsylate 500mg/5ml oral solution
0211000D0AAAEAE
|
Etamsylate | Etamsylate | Cardiovascular System | No data available |
|
Ethanolamine oleate 5% solution for injection 2ml ampoules
0213000F0AAAAAA
|
Ethanolamine oleate | Ethanolamine oleate | Cardiovascular System | No data available |
|
Ethanolamine oleate 5% solution for injection 5ml ampoules
0213000F0AAABAB
|
Ethanolamine oleate | Ethanolamine oleate | Cardiovascular System | No data available |
|
Ethibide XL 1.5mg tablets
0202010P0BGAAAD
|
Ethibide XL | Indapamide | Cardiovascular System | No data available |
|
Ethimil MR 240mg tablets
0206020T0BIAAAH
|
Ethimil | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Eucardic 12.5mg tablets
020400080BBAAAB
|
Eucardic | Carvedilol | Cardiovascular System | No data available |
|
Eucardic 25mg tablets
020400080BBABAC
|
Eucardic | Carvedilol | Cardiovascular System | No data available |
|
Eucardic 3.125mg tablets
020400080BBACAE
|
Eucardic | Carvedilol | Cardiovascular System | No data available |
|
Eucardic 6.25mg tablets
020400080BBADAF
|
Eucardic | Carvedilol | Cardiovascular System | No data available |
|
Eudemine 300mg/20ml solution for injection ampoules
0205010E0BBAAAA
|
Eudemine (Parenteral) | Diazoxide | Cardiovascular System | No data available |
|
Evana Heavy Period Relief 500mg tablets
0211000P0BFAAAC
|
Evana Heavy Period Relief | Tranexamic acid | Cardiovascular System | No data available |
|
Evolocumab 140mg/1ml inj pre-filled syringes
0212000AHAAABAB
|
Evolocumab | Evolocumab | Cardiovascular System | No data available |
|
Factor VIII (d/frac) 250u / von Willebrand factor inj vials
0211000I0AAAAAA
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Factor VIII (d/frac) 500u / von Willebrand factor inj vials
0211000I0AAAVAV
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Factor VIII 1,000u / von Willebrand factor 1,720u inf vials
0211000I0AAAXAX
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Factor VIII 1,000u/von Willebrand factor 2,400unit inj vials
0211000I0AAAMAM
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.